GUD Stock

Biopharmaceutical stocks had their ups and downs over 2021 but volatility in the sector is par for t... Read More

Paradigm Capital Markets analyst Scott McAuley is still a fan of Knight Therapeutics (Knight Therap... Read More

Raymond James analyst David Novak is firmly behind Knight Therapeutics (Knight Therapeutics Stock Qu... Read More

Stifel GMP Analyst Justin Keywood is keying back in on Knight Therapeutics (Knight Therapeutics Stoc... Read More

It’s been literally years of waiting for Canadian specialty pharma company Knight Therapeutics (Kn... Read More

A new drug acquisition is cause for a target raise on Knight Therapeutics (Knight Therapeutics Stock... Read More

It’s still early innings for specialty pharma company Knight Therapeutics (Knight Therapeutics Sto... Read More

Stifel GMP analyst Justin Keywood says investors can expect to see Knight Therapeutics (Knight Thera... Read More

With most stocks well off their 12-month highs, there are plenty of potential wins in the market the... Read More

Stifel GMP analyst Justin Keywood likes what he sees so far from Knight Therapeutics (Knight Therape... Read More

Specialty pharma company Knight Therapeutics (Knight Therapeutics Stock Quote, Chart, News TSX:GUD) ... Read More

All’s well with Knight Therapeutics (Knight Therapeutics Stock Quote, Chart, News TSX:GUD) after t... Read More

Knight Therapeutics (Knight Therapeutics Stock Quote, Chart, News TSX:GUD) is still in the early inn... Read More

The massive new acquisition of Grupo Biotoscana by Knight Therapeutics (Knight Therapeutics Stock Qu... Read More

Patience is a virtue, especially when it comes to specialty pharma name Knight Therapeutics (Knight ... Read More

It’s still early innings for Knight Therapeutics (Knight Therapeutics Stock Quote, Chart TSX:GUD),... Read More

In the ongoing fight for control of specialty pharma company Knight Therapeutics (Knight Therapeutic... Read More

Commercial-stage specialty pharma company Knight Therapeutics (Knight Therapeutics Stock Quote, Char... Read More